Effect of Pentoxifylline on Microalbuminuria in Diabetic Patients: A Randomized Controlled Trial
Table 2
Parameters of patients during the study.
Time points
Baseline
Month 3
Month 6
Albumin/creatinine ratio
Case
60.69 ± 22.04
56.98 ± 25.28
59.37 ± 28.24
Control
63.87 ± 23.26
64.51 ± 31.27
64.63 ± 27.86
value
0.77
0.41
0.58
Systolic blood pressure
Case
115.68 ± 11.16
117.73 ± 9.72
114.32 ± 11.37
Control
115.28 ± 9.15
115.28 ± 11.17
112.50 ± 11.15
value
0.90
0.46
0.61
Diastolic blood pressure
Case
75.45 ± 8.15
76.50 ± 5.72
75 ± 5.34
Control
77.29 ± 8.26
77.22 ± 6.69
77.50 ± 8.44
value
0.50
0.88
0.26
Glomerular filtration rate
Case
73.93 ± 1.05
—
73.05 ± 11.80
Control
71.54 ± 9.29
—
80.22 ± 11.97
value
0.45
—
0.06
Data expressed as mean ± SD. Case group included patients who received regular medications plus 400 mg pentoxifylline. Control group included patients who received regular medications plus placebo. values calculated by Independent Samples Test.
